European Cardiology Review
European Cardiology Review (ECR) is a bi-annual journal that undergoes peer review and includes a range of content such as review articles, editorials, and case studies. It presents well-rounded and thorough articles crafted by top experts in the field, focusing on significant advancements in cardiovascular medicine and practice. Under the leadership of Editor-in-Chief Juan Carlos Kaski and supported by a team of Associate Editors and an esteemed editorial board of highly regarded physicians, ECR publishes peer-reviewed work that seeks to deliver timely insights into the most relevant topics in cardiology.
Outlet metrics
Global
#497616
India
#141547
Health/Medicine
#613
Articles
-
1 month ago |
radcliffecardiology.com | Kieran F. Docherty |Clara Saldarriaga |Gianluigi Savarese
Learning Objectives Discuss why getting cardiorenal patients onto GDMT is challenging Recall the residual risk posed by the co-existence of heart failure and chronic kidney disease Adopt practical approaches to managing cardiorenal patients based on examples explored during this activity Detail gaps in current standards of care for cardiorenal patients Discuss ongoing efforts aimed at addressing residual risk, hyperkalaemia and clinical inertia in cardiorenal disease Target Audience...
-
1 month ago |
radcliffecardiology.com | Jonathan Byrne |Jonathan Curio |Michael G. Mullen |Patrick W. Serruys
EuroPCR 25 - Real-world findings from the REVEAL-AFMR registry show transcatheter edge-to-edge repair (TEER) is associated with improved prognosis in patients with atrial functional mitral regurgitation (AFMR). We are joined by Dr Tomohiro Kaneko (Juntendo University Graduate School of Medicine, Tokyo, JP) to discuss outcomes from a retrospective cohort study analysing data from the REVEAL-AFMR registry to investigate the impact of TEER on prognosis in patients with AFMR.
-
1 month ago |
radcliffecardiology.com | Jun Li |James Krzowski |Jonathan McCall |Michelle Morris
Video Published: Views: 8 Likes: 0 Average (ratings) SCAI 25 - Outcomes from the AVENTUS thrombectomy system for intermediate-risk pulmonary embolism show a significant improvement in right ventricular to left ventricular ratio reduction compared to the baseline measurements. The AVENTUS thrombectomy system also met the trial's safety outcome with no device-related major adverse events at 48 hours post-procedure.
-
Feb 28, 2025 |
radcliffecardiology.com | Gurleen Kaur |Saman Nematollahi |Thomas Das
Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
-
Feb 20, 2025 |
radcliffecardiology.com | Weijian Huang |Pablo Vazquez
Published content on this site is for information purposes and is not a substitute for professional medical advice. Where views/opinions are expressed, they are those of the author(s) and not of Radcliffe Medical Media. Radcliffe Cardiology is part of Radcliffe Medical Media, an independent publisher and the Radcliffe Group Ltd. It is not affiliated with or is an agent of, the Oxford Heart Centre, the John Radcliffe Hospital or the Oxford University Hospitals NHS Foundation Trust group.
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →